TY - JOUR
T1 - Approach to the discovery of novel, selective inhibitors of p56lck tyrosine kinase
T2 - Identification of non‐hydroxylated chromones as p56lck inhibitors
AU - Miller, Deborah
AU - Wang, Su
AU - Reid, John
AU - Xie, Wen
AU - Gauvin, Bruce
AU - Kelley, Marian
AU - Sarup, Jay
AU - Sawutz, David G.
AU - Miski, Muhmut
AU - Dolle, Roland E.
AU - Faltynek, Connie R.
PY - 1995/4
Y1 - 1995/4
N2 - The protein tyrosine kinase p56Ick, which is expressed predominantly in lymphocytes, plays a critical role in optimal T cell activation through the T cell antigen receptor. An approach is presented for the discovery of selective p56Ick inhibitors, which are potential immunosuppressants. A non‐radioactive assay for p56Ick tyrosine kinase activity has been developed and adapted for high volume screening. This assay does not require purified enzyme. p56Ick in the plasma membranes of a human T cell line is purified in situ by immobilization onto the wells of a microtiter plate using an antibody specific for p56Ick. Following the kinase reaction in the presence of test compound, autophosphorylated p56Ick is detected with a biotinylated monoclonal antibody to phosphotyrosine. Using the approach described in this report, three simple chromones have been identified that inhibit p56Ick autophosphorylation with low micromolar potencies and exhibit some selectivity for p56Ick over the serine/threonine and other tyrosine kinases tested. These compounds constitute a novel group of p56Ick tyrosine kinase inhibitors. ©1995 Wiley‐Liss, Inc.
AB - The protein tyrosine kinase p56Ick, which is expressed predominantly in lymphocytes, plays a critical role in optimal T cell activation through the T cell antigen receptor. An approach is presented for the discovery of selective p56Ick inhibitors, which are potential immunosuppressants. A non‐radioactive assay for p56Ick tyrosine kinase activity has been developed and adapted for high volume screening. This assay does not require purified enzyme. p56Ick in the plasma membranes of a human T cell line is purified in situ by immobilization onto the wells of a microtiter plate using an antibody specific for p56Ick. Following the kinase reaction in the presence of test compound, autophosphorylated p56Ick is detected with a biotinylated monoclonal antibody to phosphotyrosine. Using the approach described in this report, three simple chromones have been identified that inhibit p56Ick autophosphorylation with low micromolar potencies and exhibit some selectivity for p56Ick over the serine/threonine and other tyrosine kinases tested. These compounds constitute a novel group of p56Ick tyrosine kinase inhibitors. ©1995 Wiley‐Liss, Inc.
KW - T‐lymphocytes
KW - immunoenzyme techniques
KW - phosphorylation
UR - http://www.scopus.com/inward/record.url?scp=0028947501&partnerID=8YFLogxK
U2 - 10.1002/ddr.430340406
DO - 10.1002/ddr.430340406
M3 - Article
AN - SCOPUS:0028947501
SN - 0272-4391
VL - 34
SP - 344
EP - 352
JO - Drug Development Research
JF - Drug Development Research
IS - 4
ER -